Bavarian Nordic A/S

Bavarian Nordic A/S, a biotechnology company founded in 1994, is headquartered in Kvistgaard, Denmark. Specializing in infectious disease and cancer immunotherapy, Bavarian Nordic focuses on the development, manufacture, and sale of vaccines and therapies. Their portfolio prominently includes JYNNEOS, a smallpox vaccine available in the United States, which is also sold as IMVANEX in Europe and IMVAMUNE in Canada. Additionally, the firm offers an Ebola vaccine named MVABEA. Bavarian Nordic serves a global market, with the United States, Europe, and Canada being significant regions for their products. The company enjoys a key relationship with the U.S. government, which procures vaccines for national stockpiling purposes. (Powered by AI)